About: Substituted pyrazine-2,5-dicarboxamides: Synthesis, Hydrophobicity Parameters and Antimycobacterial Evaluation     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Substituted pyrazine derivatives were synthesized and tested against Mycobacterium tuberculosis strain H37Rv. The hydrophobicity of all the pyrazines was determined using the reversed phase high performance liquid chromatography (RP-HPLC) method (isocratic elution with methanol as an organic modifier in the mobile phase, end-capped non-polar C18 stationary RP column). Experimentally derived Log K values (the logarithm of capacity factor K) were that compared with Log P values calculated by commercially available programmes. The synthetic approach, analytical, spectroscopic, lipophilicity and biological data of ten newly synthesized compounds are presented. Structure?activity relationships among the chemical structure, the antimycobacterial activity of the evaluated compounds are discussed. 3-(3-Methylphenyl)-aminopyrazine-2,5- dicarboxamide (7) has shown the highest activity against M. tuberculosis H37Rv (63% inhibition).
  • Substituted pyrazine derivatives were synthesized and tested against Mycobacterium tuberculosis strain H37Rv. The hydrophobicity of all the pyrazines was determined using the reversed phase high performance liquid chromatography (RP-HPLC) method (isocratic elution with methanol as an organic modifier in the mobile phase, end-capped non-polar C18 stationary RP column). Experimentally derived Log K values (the logarithm of capacity factor K) were that compared with Log P values calculated by commercially available programmes. The synthetic approach, analytical, spectroscopic, lipophilicity and biological data of ten newly synthesized compounds are presented. Structure?activity relationships among the chemical structure, the antimycobacterial activity of the evaluated compounds are discussed. 3-(3-Methylphenyl)-aminopyrazine-2,5- dicarboxamide (7) has shown the highest activity against M. tuberculosis H37Rv (63% inhibition). (en)
  • Substituované deriváty pyrazinu byly připraveny a testovány proti Mycobacterium tuberculosis, kmen H37Rv. Hydrofobicita všech pyrazinových derivátů by stanovena pomocí metody RP-HPLC (isokratická eluce mobilní fází s methanolem jako organickým modifikátorem, kolona s C18 endkapovanou nepolární stacionární fází). Experimentálně zjištěné hodnoty log K byly porovnány s hodnotami log P vypočítanými komerčně dostupnými programy. V článku je prezentována syntéza, analytická, lipofilitní a biologická data deseti nově syntetizovaných látek. Vztahy mezi strukturou a antimykobakteriální aktivitou jsou obsaženy v diskusi. Nejvyšší aktivitu proti M. tuberculosis H37Rv vykázal 3-(3-Methylfenyl)-aminopyrazin-2,5-dicarboxamid (7) ? 63% inhibice. (cs)
Title
  • Substituted pyrazine-2,5-dicarboxamides: Synthesis, Hydrophobicity Parameters and Antimycobacterial Evaluation
  • Substituované pyrazin-2,5-dikarboxamidy: syntéza, hydrofobní parametry a antimykobakteriální hodnocení (cs)
  • Substituted pyrazine-2,5-dicarboxamides: Synthesis, Hydrophobicity Parameters and Antimycobacterial Evaluation (en)
skos:prefLabel
  • Substituted pyrazine-2,5-dicarboxamides: Synthesis, Hydrophobicity Parameters and Antimycobacterial Evaluation
  • Substituované pyrazin-2,5-dikarboxamidy: syntéza, hydrofobní parametry a antimykobakteriální hodnocení (cs)
  • Substituted pyrazine-2,5-dicarboxamides: Synthesis, Hydrophobicity Parameters and Antimycobacterial Evaluation (en)
skos:notation
  • RIV/62157124:16370/07:00001121!RIV08-MSM-16370___
http://linked.open.../vavai/riv/strany
  • 005-015
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • S
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 453429
http://linked.open...ai/riv/idVysledku
  • RIV/62157124:16370/07:00001121
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Pyrazinecarboxamides; In vitro antimycobacterial activity; Lipophilicity determination (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...ontrolniKodProRIV
  • [DD52AB81C381]
http://linked.open...i/riv/mistoVydani
  • Basel
http://linked.open...i/riv/nazevZdroje
  • Proceedings of 11th International Electronic Conference on Synthetic Organic Chemistry
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...iv/tvurceVysledku
  • Doležal, Martin
  • Jampílek, Josef
  • Kuneš, Jiří
  • Bielesz, Stanislav
number of pages
http://purl.org/ne...btex#hasPublisher
  • Molecular Diversity Preservation International (MDPI)
https://schema.org/isbn
  • 3-906980-19-7
http://localhost/t...ganizacniJednotka
  • 16370
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software